| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66532283 |
| PharmacoGx | BRD-K66532283 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PTGR1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | LAMA5 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | TCP10L | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | INSL3 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | UHRF1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | RXFP4 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | UTP3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | SMARCB1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | IL4I1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | GPR63 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
